Skip to content

MRK vs WST: Dividend Comparison

MRK$121.49
Merck & Co., Inc.
Health Care
vs
WST$248.04
West Pharmaceutical Services Inc
Health Care

Dividend data as of

Merck & Co., Inc. (MRK) and West Pharmaceutical Services Inc (WST) are both in the Health Care sector, making them natural rivals for dividend investors. MRK offers a significantly higher 2.77% yield compared to WST's 0.34%, a gap of 2.42%. For dividend growth, WST leads with a 5-year CAGR of 13.1% versus MRK's 5.9%. Both stocks carry a "Safe" dividend safety rating. MRK is a Dividend Contender with 15 years of consecutive increases.

Verdict

Best for Income
MRK
Higher yield at 2.77%
Best for Growth
WST
5yr CAGR of 13.1%
Best for Safety
WST
Lower payout ratio (12%)
Metric
Price
$121.49
$248.04
Dividend Yield
2.77%
0.34%
Annual Dividend
$3.24
$0.84
5yr Div CAGR
5.9%
13.1%
3yr Div CAGR
5.3%
21.1%
Consecutive Years
15
0
Payout Ratio
45.05%
12.44%
P/E Ratio
Market Cap
Income on $10k
$277/yr
$34/yr

Yield Analysis

MRK
2.77%
WST
0.34%

MRK yields 2.42% more than WST. In dollar terms, MRK pays $3.24/share vs WST's $0.84/share annually.

Dividend Growth

MRK 5yr CAGR
5.9%
decelerating
WST 5yr CAGR
13.1%
accelerating

MRK: Dividend growth is slowing — the 3-year CAGR of 5.3% trails the 5-year rate of 5.9% and the 10-year rate of 7.1%.

WST: Dividend growth is accelerating — the 3-year CAGR of 21.1% exceeds the 5-year rate of 13.1% and the 10-year rate of 9.7%.

Dividend Safety

MRK
Safe
Payout Ratio45%
WST
Safe
Payout Ratio12%

MRK: The payout ratio of 45% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 2.2x.

WST: The payout ratio of 12% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 8.0x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
MRK
WST
$10,000
$277/yr
$34/yr
$50,000
$1,383/yr
$172/yr
$100,000
$2,766/yr
$345/yr

What does $10,000 buy in MRK vs WST today?

At $121.49 per share, $10,000 buys about 82.3 shares of Merck & Co., Inc. (MRK). Each share pays $3.24 per year in dividends, so the position starts out generating roughly $267 per year — about $22 a month.

At $248.03 per share, $10,000 buys about 40.3 shares of West Pharmaceutical Services Inc (WST). Each share pays $0.84 per year in dividends, so the position starts out generating roughly $34 per year — about $3 a month.

MRK is the larger income stream from day one: $233 per year more on the same $10,000 invested.

What could $10,000 of MRK or WST income look like in 10 years?

Merck & Co., Inc. (MRK) has raised its dividend about 5.9% a year over the past five years. If that pace held, the $277 per year that $10,000 generates today at the current 2.77% yield would reach $490 per year by 2036 — a 4.9% yield on the original cost.

West Pharmaceutical Services Inc (WST) has raised its dividend about 13.1% a year over the past five years. If that pace held, the $34 per year that $10,000 generates today at the current 0.34% yield would reach $118 per year by 2036 — a 1.2% yield on the original cost.

On those trailing rates, MRK pays more in 2036: $490 versus $118 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would WST's dividend growth overtake MRK's higher yield?

Not within a realistic holding period. West Pharmaceutical Services Inc (WST) is growing its dividend faster (13.1% vs 5.9% a year), but the starting-yield gap — 2.77% for MRK vs 0.34% for WST — is wide enough that the crossover sits more than 30 years out on trailing rates. For income you plan to spend, MRK's head start is decisive.

Can MRK and WST afford their dividends?

Merck & Co., Inc. (MRK) earns $7.28 per share against $3.24 paid out in dividends — 2.2x coverage (a 45% payout ratio).

West Pharmaceutical Services Inc (WST) earns $6.75 per share against $0.84 paid out in dividends — 8.0x coverage (a 12% payout ratio).

WST's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for MRK if earnings weaken.

Which fits an early-retirement income portfolio better, MRK or WST?

For income you need right now, Merck & Co., Inc. (MRK) leads: $100,000 invested today pays about $230 a month at the current 2.77% yield, versus $29 a month from West Pharmaceutical Services Inc (WST) at 0.34%.

With a decade or more before the income is needed, WST's faster dividend growth (13.1% vs 5.9% a year) matters more than the starting yield — raises compound into the larger paycheck over time.

On consistency: MRK has raised its dividend 15 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $643/yr in MRK vs $122/yr in WST by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Track MRK and WST in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.